Lung Cancer. Emerging Cancer Therapeutics

Description

This issue of Emerging Cancer Therapeutics provides a comprehensive review for practitioners on the current status of lung cancer treatment. Lung cancer treatment has undergone major changes over the course of the past few years and the pace of new research and development is expected to continue at a high level for the immediate future. Lung Cancer addresses current best practices in the light of the most recent evidence and new developments in this field. All of the chapters are written by international experts in the field, address the common clinical scenarios in Lung cancer and are multidisciplinary in scope. Coverage includes discussion of prevention, screening, surgery, radiation therapy, chemotherapy, immunotherapy, new therapeutic approaches, and more.

Emerging Cancer Therapeutics features:

• Editorial board of nationally recognized experts across the spectrum of Cancer Therapeutics
• In-depth, up-to-date expert reviews and analysis of major new developments in all areas of Cancer Therapeutics
• Issues edited by an authority in specific subject area
• Focuses on major topics in Cancer Therapeutics with in-depth articles covering advances in clinical and translational research developments, as well as clinical applications and experience
• Emphasizes multidisciplinary approaches to research and practice

Contents

1. Molecular Biology of Lung Cancer and Therapeutic Implications, Tobenna Nwizu and Ravi Salgia;
2. Chemotherapy Options for Advanced Non-Small Cell Lung Cancer, Vassilis Georgoulias;
3. Pros and Cons of Maintenance Therapy for Advanced Non-Small Cell Lung Cancer, A. Kostsakis, E. Kontopodis, and Vassilis Georgoulias;
4. Targeting Angiogenesis in Lung Cancer, Geetha Vallabhaneni and Suresh Ramalingam;
5. Emerging Novel Targeted Agents for Lung Cancer, Rathi N. Pillai and Taofeek K Owonikoko;
6. State-of-the-Art Treatment of Lung Cancer in the Elderly, Antonio Rossi;
7. Surgical Approaches to Early-Stage Lung Cancer, Rodney Landreneau;
8. Advances in the First-and Second-Line Chemotherapy of Small Cell Lung Cancer, Shir Kiong Lu, Patrizia Giannatempo, and Mary O'Brien;
9. Adjuvant Chemotherapy for Early-Stage Non-Small Cell Lung Cancer, Manili I. Patel and Heather A. Wakelee;
10. Advances in Radiotherapy for Lung Cancer, Neha Amin, David Raben, and Laurie Gaspar;
11. Emerging Concepts in the Treatment of EGFR Mutation Positive Lung Cancer, Dustin A. Deming and Anne M. Traynor

About the Guest Editors

Antanassios Argiris, MD, FACP, Chief, Division of Hematology-Oncology, UT Health Science Center, San Antonio Cancer therapy and Research Center

Jame Abraham, MD, FACP, Bonnie Wells Wilson Distinguished Professor and Eminent Scholar, Chief, Section of Hematology-Oncology, Medical Director, Mary Babb Randolph Cancer Center West Virginia University